As of 11:31 AM on the 22nd, SK Chemicals is trading at 421,500 KRW, up 0.6% from the previous day. The trading volume is 252,989 shares, which is about 28.72% of the previous day's volume. SK Chemicals is known as a manufacturer of eco-friendly materials, energy, and biopharmaceuticals.
On January 20, Seogeunhee, a researcher at Samsung Securities, stated, "SK Bioscience plans to produce, distribute, and sell the Novavax COVID-19 vaccine domestically. The Korean government intends to pre-purchase all 40 million doses. The domestic approval of Novavax is expected as early as Q2 2021. Interim results of the Novavax Phase 3 clinical trial in the UK are expected to be announced in Q1 2021. Assuming the Ministry of Food and Drug Safety reviews emergency use authorization based on these results, sales in Korea are expected in Q2 2021." The target price for SK Chemicals was set at 550,000 KRW.
Over the past five days, individual investors have net sold 501,581 shares of SK Chemicals, while foreigners and institutions have net bought 373,139 shares and 124,040 shares, respectively.
※Source: AI Investment Assistant AI Rassiro
※ This article was generated in real-time by an article auto-generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
